Rami Abou Ghaida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rami Abou Ghaida has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Mohammed Shahait
Department of Urology, University of California Irvine, Orange, USA
3 shared publications - Rami Wajih Nasr
American University of Beirut Medical Center
3 shared publications - Ali Shamseddine
Division of Hematology/Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
2 shared publications - Ibrahim Abu Gheida
Department of Radiation Oncology, The Naef K. Basile Cancer Institute at the American University of Beirut Medical Center, Bliss Street, Riad El Solh, Beirut, 11072030, Lebanon
2 shared publications - Maya Charafeddine
American University of Beirut Medical Center 1 Hematology-Oncology Division Beirut, Lebanon
2 shared publications Samer L. Traboulsi
Division of Urology, Department of Surgery, American University of Beirut, Beirut, Lebanon
2 shared publications
Latest Publications
- Open Access
- 7 September 2017
- Published by Springer Nature in Radiation Oncology
- Vol. 12 (1) , 149
Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation
The aim of this study is to investigate the effect of tumor characteristics and parameters of treatment response in predicting biochemical disease-free survival (BFS) for patients with intermediate or high risk prostate cancer treated by combined definitive external beam radiation therapy (EBRT) and androgen deprivation therapy (ADT). Between June 1995 and January 2015, 375 patients with localized prostate cancer and a National Comprehensive Cancer Network (NCCN) intermediate or high risk categories were treated by definitive EBRT and ADT. Median duration of androgen blockade was 10 months (range: 3–36 months); Median radiation dose was 72 Gy (Range: 70–78 Gy). Median follow-up time was 5.8 years (range: 0.8–16.39 years). The main study endpoint was biochemical disease free survival (BFS). Forty seven patients (12.5%) developed biochemical recurrence (BCR) during the observation period. Monovariate analysis identified baseline PSA (bPSA) (p = 0.024), T-stage (p = 0.001), Gleason’s score (GS) (p = 0.042), radiation dose (p = 0.045), PSA pre-radiation therapy (p = 0.048), and nadir PSA (nPSA), (p < 0.001) as significant variables affecting BCR. The receiver operating characteristic (ROC) curve identified a nPSA of 0.06 ng/ml as optimal cut-off value significantly predicting the patients’ risk of BCR (p < 0.001). Multivariate cox regression analysis revealed T-stage, GS, and nPSA as independent variable affecting BFS, while bPSA, age, and radiation dose were not. Nadir PSA at 0.06 is a strong independent predictor of BFS in patients with intermediate or high risk prostate cancer treated by definitive EBRT and ADT.
- 7 September 2017
- Published by Springer Nature in Radiation Oncology
- Vol. 12 (1) , 149
Open AccessNadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation
The aim of this study is to investigate the effect of tumor characteristics and parameters of treatment response in predicting biochemical disease-free survival (BFS) for patients with intermediate or high risk prostate cancer treated by combined definitive external beam radiation therapy (EBRT) and androgen deprivation therapy (ADT). Between June 1995 and January 2015, 375 patients with localized prostate cancer and a National Comprehensive Cancer Network (NCCN) intermediate or high risk categories were treated by definitive EBRT and ADT. Median duration of androgen blockade was 10 months (range: 3–36 months); Median radiation dose was 72 Gy (Range: 70–78 Gy). Median follow-up time was 5.8 years (range: 0.8–16.39 years). The main study endpoint was biochemical disease free survival (BFS). Forty seven patients (12.5%) developed biochemical recurrence (BCR) during the observation period. Monovariate analysis identified baseline PSA (bPSA) (p = 0.024), T-stage (p = 0.001), Gleason’s score (GS) (p = 0.042), radiation dose (p = 0.045), PSA pre-radiation therapy (p = 0.048), and nadir PSA (nPSA), (p < 0.001) as significant variables affecting BCR. The receiver operating characteristic (ROC) curve identified a nPSA of 0.06 ng/ml as optimal cut-off value significantly predicting the patients’ risk of BCR (p < 0.001). Multivariate cox regression analysis revealed T-stage, GS, and nPSA as independent variable affecting BFS, while bPSA, age, and radiation dose were not. Nadir PSA at 0.06 is a strong independent predictor of BFS in patients with intermediate or high risk prostate cancer treated by definitive EBRT and ADT.
- Open Access
- 26 December 2014
- Published by Science Publishing Group in International Journal of Nutrition and Food Sciences
- Vol. 4 (2) , 1-5
Review of Meat and Caffeine and the Risk of Bladder Cancer
Bladder cancer (BCa) is a main health issue in both developed and developing countries, especially for men with an incidence that is three to five times greater than that of women. The majority of bladder cancer occurs in males and there is a 14-fold variation in the incidence internationally. About 1,596,670 new cancer cases were diagnosed in 2011. This estimate did not include carcinoma in situ (noninvasive cancer) of any site except urinary bladder. It is commonly known that nutrition has a role in preventing cancer in general. Additionally, new dispute has risen over the effect of dietary factors such as meat and coffee in bladder cancer, which has yielded contradicting results. The review relied on previous researches and studies related to our assumption that meat and caffeine intake is not proved to be directly related to BCa. The study showed that there is no credible evidence stating that BCa is the result of meat and caffeine intake. This was due to the contradiction found in the studies referred to or consulted in the study. The lack of statistical association of meat types, the different methods of cooking, samples under study, and lifestyle enrollment are all considered important variables that were neglected in previous researches. These limitations supported the lack of credibility of such studies that correlated BCa to meat and caffeine intake.
- 26 December 2014
- Published by Science Publishing Group in International Journal of Nutrition and Food Sciences
- Vol. 4 (2) , 1-5
Open AccessReview of Meat and Caffeine and the Risk of Bladder Cancer
Bladder cancer (BCa) is a main health issue in both developed and developing countries, especially for men with an incidence that is three to five times greater than that of women. The majority of bladder cancer occurs in males and there is a 14-fold variation in the incidence internationally. About 1,596,670 new cancer cases were diagnosed in 2011. This estimate did not include carcinoma in situ (noninvasive cancer) of any site except urinary bladder. It is commonly known that nutrition has a role in preventing cancer in general. Additionally, new dispute has risen over the effect of dietary factors such as meat and coffee in bladder cancer, which has yielded contradicting results. The review relied on previous researches and studies related to our assumption that meat and caffeine intake is not proved to be directly related to BCa. The study showed that there is no credible evidence stating that BCa is the result of meat and caffeine intake. This was due to the contradiction found in the studies referred to or consulted in the study. The lack of statistical association of meat types, the different methods of cooking, samples under study, and lifestyle enrollment are all considered important variables that were neglected in previous researches. These limitations supported the lack of credibility of such studies that correlated BCa to meat and caffeine intake.
- Open Access
- 19 September 2014
- Published by Springer Nature in BMC Urology
- Vol. 14 (1) , 76
Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis
Inflammation is a critical component of tumorigenesis, and many cancers arise from sites of infection, chronic irritation, and inflammation. Inflammatory cytokines triggered by tumors alter hematologic components, including neutrophil, lymphocyte, and monocyte counts. The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios have been shown to be valuable prognostic markers in various types of cancers, including bladder cancer. Risk stratification based on clinicopathologic data is insufficient to support treatment-related choices in patients with bladder cancer. Novel prognostic markers are therefore needed. An elevated pretreatment lymphocyte-to-monocyte ratio (LMR) is reportedly associated with improved overall survival (OS) and a longer time to treatment recurrence (TTR) in some types of cancers. However, these data are lacking in patients with bladder cancer. The aim of the present study was to investigate the effect of the preoperative LMR on OS and TTR in a cohort of patients with bladder cancer.
- 19 September 2014
- Published by Springer Nature in BMC Urology
- Vol. 14 (1) , 76
Open AccessPreoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis
Inflammation is a critical component of tumorigenesis, and many cancers arise from sites of infection, chronic irritation, and inflammation. Inflammatory cytokines triggered by tumors alter hematologic components, including neutrophil, lymphocyte, and monocyte counts. The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios have been shown to be valuable prognostic markers in various types of cancers, including bladder cancer. Risk stratification based on clinicopathologic data is insufficient to support treatment-related choices in patients with bladder cancer. Novel prognostic markers are therefore needed. An elevated pretreatment lymphocyte-to-monocyte ratio (LMR) is reportedly associated with improved overall survival (OS) and a longer time to treatment recurrence (TTR) in some types of cancers. However, these data are lacking in patients with bladder cancer. The aim of the present study was to investigate the effect of the preoperative LMR on OS and TTR in a cohort of patients with bladder cancer.
- Open Access
- 1 May 2014
- Published by Elsevier in Urology Case Reports
- Vol. 2 (3) , 89-92
Renal Angiomyxolipoma: Its First Appearance!
- 1 May 2014
- Published by Elsevier in Urology Case Reports
- Vol. 2 (3) , 89-92
Open AccessRenal Angiomyxolipoma: Its First Appearance!
- Open Access
- 27 November 2013
- Published by Wiley in Case Reports in Urology
- Vol. 2013, 1-4
Iatrogenic Penile Glans Amputation: Major Novel Reconstructive Procedure
Circumcision is a very common urological practice. Even though it is relatively safe, it is not a complication-free procedure. We describe a patient that underwent a neonatal circumcision complicated by iatrogenic complete glans amputation. Reconstructive repair of a neoglans using a modified traditional method was used. Postoperative followup to 90 days is illustrated. Despite being a simple procedure, circumcision in unprofessional hands can have major complication impacting the emotional and sexual life of patients. Surgical reconstruction is possible with varying satisfactory results.
- 27 November 2013
- Published by Wiley in Case Reports in Urology
- Vol. 2013, 1-4
Open AccessIatrogenic Penile Glans Amputation: Major Novel Reconstructive Procedure
Circumcision is a very common urological practice. Even though it is relatively safe, it is not a complication-free procedure. We describe a patient that underwent a neonatal circumcision complicated by iatrogenic complete glans amputation. Reconstructive repair of a neoglans using a modified traditional method was used. Postoperative followup to 90 days is illustrated. Despite being a simple procedure, circumcision in unprofessional hands can have major complication impacting the emotional and sexual life of patients. Surgical reconstruction is possible with varying satisfactory results.
- Open Access
- 22 August 2013
- Published by BMJ in BMJ Case Reports
- Vol. 2013, 200153
Bladder perivascular epithelioid cell tumours
Perivascular epithelioid cell tumours, better known as PECOMAs, are a very uncommon pathological finding. In English medical literature it has rarely been reported. In the genitourinary system, mostly urinary bladder, the incidence is as low as 10 cases described since 2003 until now. In this case report, we present a urinary bladder PECOMA with a detailed pathological description and a review of literature.
- 22 August 2013
- Published by BMJ in BMJ Case Reports
- Vol. 2013, 200153
Open AccessBladder perivascular epithelioid cell tumours
Perivascular epithelioid cell tumours, better known as PECOMAs, are a very uncommon pathological finding. In English medical literature it has rarely been reported. In the genitourinary system, mostly urinary bladder, the incidence is as low as 10 cases described since 2003 until now. In this case report, we present a urinary bladder PECOMA with a detailed pathological description and a review of literature.